Plasma omega-3 PUFA and white matter mediated executive decline in older adults

Frontiers in Aging Neuroscience

Volumn 5, Issue DEC, 2013, Pages

  Bowman, Gene L ^a   Dodge, Hiroko H ^a   Mattek, Nora ^a   Barbey, Aron K ^b   Silbert, Lisa C ^a   Shinto, Lynne ^a   Howieson, Diane B ^a   Kaye, Jeffrey A ^a   Quinn, Joseph F ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Cognitive decline; Hypertension; Memory; Omega 3 fatty acids; White matter hyperintensity

Indexed keywords

EID: 84894463171     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2013.00092     Document Type: Article

References (41)

1. Adak, S., Illouz, K., Gorman, W., Tandon, R., Zimmerman, E. A., Guariglia, R. (2004). Predicting the rate of cognitive decline in aging and early Alzheimer disease. Neurology 63, 108-114. doi: 10.1212/01.WNL.0000132520. 69612.AB
2. Barbey, A. K., Colom, R., Solomon, J., Krueger, F., Forbes, C., and Grafman, J. (2012). An integrative architecture for general intelligence and exec-utive function revealed by lesion mapping. Brain 135, 1154-1164. doi: 10.1093/brain/aws021
3. Baron, R. M., and Kenny, D. A. (1986). The moderator-mediator variable dis-tinction in social psychological research: conceptual, strategic, and statisti-cal considerations. J. Pers. Soc. Psychol. 51, 1173-1182. doi: 10.1037/0022-3514.51.6.1173
4. Bastos Leite, A. J., van der Flier, W. M., van Straaten, E. C., Scheltens, P., and Barkhof, F. (2006). Infratentorial abnormalities in vascular dementia. Stroke 37, 105-110. doi: 10.1161/01.STR.0000196984.90718.8a
5. Beydoun, M. A., Kaufman, J. S., Satia, J. A., Rosamond, W., and Folsom, A. R. (2007). Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities Study. Am. J. Clin. Nutr. 85, 1103-1111.
6. Bowman, G. L., Shannon, J., Ho, E., Traber, M. G., Frei, B., Oken, B. S., Kaye, J. A., and Quinn, J. F. (2011). Reliability and validity of food frequency questionnaire and nutrient biomarkers in elders with and without mild cognitive impairment. Alzheimer Dis. Assoc. Disord. 25, 49-57. doi: 10.1097/WAD.0b013e3181f333d6
7. Bowman, G. L., Silbert, L. C., Howieson, D., Dodge, H. H., Traber, M. G., Frei, B., et al. (2012). Nutrient biomarker patterns, cognitive func-tion, and MRI measures of brain aging. Neurology 78, 241-249. doi: 10.1212/WNL.0b013e3182436598
8. Brickman, A. M., Zimmerman, M. E., Paul, R. H., Grieve, S. M., Tate, D. F., Cohen, R. A., et al. (2006). Regional white matter and neuropsychologi-cal functioning across the adult lifespan. Biol. Psychiatry 60, 444-453. doi: 10.1016/j.biopsych.2006.01.011
9. Dangour, A. D., Allen, E., Elbourne, D., Fasey, N., Fletcher, A. E., Hardy, P. et al. (2010). Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial. Am. J. Clin. Nutr. 91, 1725-1732. doi: 10.3945/ajcn.2009.29121
10. Danthiir, V., Burns, N. R., Nettelbeck, T., Wilson, C., and Wittert, G. (2011). The older people, omega-3, and cognitive health (EPOCH) trial design andmethod-ology: a randomised, double-blind, controlled trial investigating the effect of long-chain omega-3 fatty acids on cognitive ageing and wellbeing in cognitively healthy older adults. Nutr. J. 10, 117. doi: 10.1186/1475-2891-10-117
11. Debette, S., Beiser, A., DeCarli, C., Au, R., Himali, J. J., Kelly-Hayes, M., et al. (2010). Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study. Stroke 41, 600-606. doi: 10.1161/STROKEAHA.109.570044
12. DeCarli, C.,Murphy, D. G., Tranh,M., Grady, C. L., Haxby, J. V., Gillette, J. A., et al. (1995). The effect of white matter hyperintensity volume on brain structure cognitive performance, and cerebralmetabolism of glucose in 51 healthy adults. Neurology 45, 2077-2084. doi: 10.1212/WNL.45.11.2077
13. deLeeuw,F.E.,deGroot,J.C.,Achten,E.,Oudkerk,M.,Ramos,L.M.,Heijboer, R., et al. (2001). Prevalence of cerebral white matter lesions in elderly peo-ple: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J. Neurol. Neurosurg. Psychiatry 70, 9-14. doi: 10.1136/jnnp. 70.1.9
14. Folstein, M. F., Folstein, S. E., and McHugh, P. R. (1975). "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12, 189-198. doi: 10.1016/002-3956(75)90026-6
15. Garde, E., Lykke Mortensen, E., Rostrup, E., and Paulson, O. B. (2005). Decline in intelligence is associated with progression in white matter hyperintensity volume. J. Neurol. Neurosurg. Psychiatry 76, 1289-1291. doi: 10.1136/jnnp.2004.055905
16. Geleijnse, J. M., Giltay, E. J., and Kromhout, D. (2012). Effects of n-3 fatty acids on cognitive decline: A randomized, double-blind, placebo-controlled trial in stable myocardial infarction patients. Alzheimers Dement. 8, 278-287. doi: 10.1016/j.jalz.2011.06.002
17. Gorelick, P. B., Scuteri, A., Black, S. E., Decarli, C., Greenberg, S. M., Iadecola, C., et al. (2011). Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart associa-tion/american stroke association. Stroke 42, 2672-2713. doi: 10.1161/STR.0b013 e3182299496
18. Jackson, P. A., Reay, J. L., Scholey, A. B., and Kennedy, D. O. (2012). Docosahexaenoic acid-rich sh oil modulates the cerebral hemodynamic response to cognitive tasks in healthy young adults. Biol. Psychol. 89, 183-190. doi: 10.1016/j.biopsycho.2011.10.006
19. Kaye, J. A., Oken, B. S., Howieson, D. B., Howieson, J., Holm, L. A., and Dennison, K. (1994). Neurologic evaluation of the optimally healthy oldest old. Arch. Neurol. 51, 1205-1211. doi: 10.1001/archneur.1994.00540240049015
20. Kiernan, R. J., Mueller, J., Langston, J. W., and Van Dyke, C. (1987). The Neurobehavioral Cognitive Status Examination: a brief but quantitative approach to cognitive assessment. Ann. Intern. Med. 107, 481-485. doi: 10.7326/0003-4819-107-4-481
21. Kramer, J. H., Mungas, D., Reed, B. R., Wetzel, M. E., Burnett, M. M., Miller, B. L., Weiner, M. W., and Chui, H. C. (2007). Longitudinal MRI and cognitive change in healthy elderly. Neuropsychology 21, 412-418. doi: 10.1037/0894-4105.21.4.412
22. Kuczynski, B., Targan, E., Madison, C., Weiner, M., Zhang, Y., Reed, B., et al. (2010). White matter integrity and cortical metabolic associations in aging and dementia. Alzheimers Dement. 6, 54-62. doi: 10.1016/j.jalz.2009.04.1228
23. Morris, J. C. (1993). The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43, 2412-2414. doi: 10.1212/WNL.43.11.2412-a
24. Mozaffarian, D., andWu, J. H. (2011). Omega-3 fatty acids and cardiovascular dis-ease: effects on risk factors, molecular pathways, and clinical events. J. Am. Coll. Cardiol. 58, 2047-2067. doi: 10.1016/j.jacc.2011.06.063
25. Mueller, E. A., Moore, M. M., Kerr, D. C., Sexton, G., Camicioli, R. M., Howieson, D. B., et al. (1998). Brain volume preserved in healthy elderly through the eleventh decade. Neurology 51, 1555-1562. doi: 10.121/WNL. 51.6.1555
26. Pu, H., Guo, Y., Zhang,W., Huang, L.,Wang, G., Liou, A. K., et al. (2013). Omega-3 polyunsaturated fatty acid supplementation improves neurologic recovery and attenuates white matter injury after experimental traumatic brain injury. J. Cereb. Blood Flow Metab. 33, 1474-1484. doi: 10.1038/jcbfm.2013.108
27. Reitan, R. M. (1958). Validity of the trail making test as an indicator of organic brain damage. Percept. Motor Skills 8, 271-276.
28. Samieri, C., Feart, C., Proust-Lima, C., Peuchant, E., Dartigues, J. F., Amieva, H., et al. (2011). Omega-3 fatty acids and cognitive decline: modulation by ApoEepsilon4 allele and depression. Neurobiol. Aging 32, 2317 e13-2317 e22. doi: 10.1016/j.neurobiolaging.2010.03.020
29. Schmidt, R., Fazekas, F., Offenbacher, H., Dusek, T., Zach, E., Reinhart, B., et al. (1993). Neuropsychologic correlates of MRI white matter hyperin-tensities: a study of 150 normal volunteers. Neurology 43, 2490-2494. doi: 10.1212/WNL.43.12.2490
30. Schmidt, R., Schmidt, H., Kapeller, P., and Fazekas, F. (2003). Slow progres-sion of white-matter changes. Int. Psychogeriatr. 15(Suppl. 1), 173-176. doi: 10.1017/S1041610203009153
31. Silbert, L. C., Dodge, H. H., Perkins, L. G., Sherbakov, L., Lahna, D., Erten-Lyons, D., et al. (2012). Neurology 79, 741-747. doi: 10.1212/WNL.0b013e3182661f2b
32. Silbert, L. C., Howieson, D. B., Dodge, H., and Kaye, J. A. (2009). Cognitive impairment risk: white matter hyperintensity progression matters. Neurology 73, 120-125. doi: 10.1212/WNL.0b013e3181ad53fd
33. Silbert, L. C.,Nelson, C., Howieson, D. B., Moore, M. M., and Kaye, J. A. (2008). Impact of white matter hyperintensity volume progression on rate of cognitive and motor decline. Neurology 71, 108-113. doi: 10.1212/01.wnl.0000316799.86917.37
34. Tan, Z. S., Harris, W. S., Beiser, A. S., Au, R., Himali, J. J., Debette, S., et al. (2012). Red blood cell omega-3 fatty acid levels and markers of accel-erated brain aging. Neurology 78, 658-664. doi: 10.1212/WNL.0b013e318 249f6a9
35. Tangney, C. C., and Scarmeas, N. (2012). The good, bad, and ugly?: How blood nutrient concentrationsmay reect cognitive performance. Neurology 78, 230-231. doi: 10.1212/WNL.0b013e31824367da
36. vandeRest,O.,Geleijnse,J.M.,Kok,F.J.,vanStaveren,W.A.,Dullemeijer,C., Olderikkert, M. G., et al. (2008). Effect of sh oil on cognitive performance in older subjects: a randomized, controlled trial. Neurology 71, 430-438. doi: 10.1212/01.wnl.0000324268.45138.86
37. Verdelho, A., Madureira, S., Ferro, J. M., Basile, A. M., Chabriat, H., Erkinjuntti, T., et al. (2007). Differential impact of cerebral white matter changes, dia-betes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS study. J. Neurol. Neurosurg. Psychiatry 78, 1325-1330. doi: 10.1136/jnnp.2006.110361
38. Virtanen, J. K., Siscovick, D. S., Lemaitre, R. N., Longstreth, W. T., Spiegelman, D., Rimm, E. B., et al. (2013). Circulating omega-3 polyunsaturated fatty acids and subclinical brain abnormalities on MRI in older adults: the cardiovas-cular health study. J. Am. Heart Assoc. 2, e000305. doi: 10.1161/JAHA.113. 000305
39. Virtanen, J. K., Siscovick, D. S., Longstreth, W. T., Kuller, L. H. Jr., and Mozaffarian, D. (2008). Fish consumption and risk of subclinical brain abnormalities on MRI in older adults. Neurology 71, 439-446. doi: 10.1212/01.wnl.0000324414.12665.b0
40. Wechsler, D. (1981). Manual for the Wechsler Adult Intelligence Revised. San Antonio: The Psychological Corporation.
41. Yang, Y., Lu, N., Chen, D., Meng, L., Zheng, Y., and Hui, R. (2012). Effects of n-3 PUFA supplementation on plasma soluble adhesion molecules: a meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 95, 972-980. doi: 10.3945/ajcn.111.025924